Share
The LOOP Zurich, the new medical research center in Zurich, promotes patient-focused therapies. To achieve its goals, the center brings together specialist knowledge in the fields of biomedicine, bioinformatics and clinical research from the University of Zurich, ETH Zurich as well as Zurich’s four university hospitals. Two of The LOOP Zurich’s first research consortia have now started developing innovative treatments methods in oncology and neurorehabilitation.
Patients differ. The more precise the diagnosis and the more targeted the therapy, the better the individual needs of patients can be met. This is the goal of The LOOP Zurich. The new translational research center wants to improve our basic understanding of diseases to develop therapies that are tailored to the individual. To this end, it combines basic research in biomedicine and bioinformatics from the University of Zurich (UZH) and ETH Zurich with clinical research from the University’s four hospitals – the
E-Mail
Researchers at the University of Zurich show that increased sensitivity in a specific region of the brain contributes to the development of anxiety and depression in response to real-life stress. Their study establishes an objective neurobiological measure for stress resilience in humans.
Some people don t seem to be too bothered when it comes to handling stress. For others, however, prolonged exposure to stress can lead to symptoms of anxiety and depression. While stress resilience is a widely discussed concept, it is still very challenging to predict people s individual response to increased levels of stress. Lab experiments can only go so far in replicating the chronic stress many people experience in their day-to-day lives, as stress simulated in the lab is always limited in exposure time and intensity.
UZH study establishes an objective neurobiological measure for stress resilience news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
The U.S. new cases 7-day rolling average are 12.2 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now - %
LOWER [not updated] than the rolling average one week ago. U.S. deaths due to coronavirus are now 16.2 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 57,417
U.S. Coronavirus hospitalizations are at 40,212 (not updated)
U.S. Coronavirus deaths are at 1,947
U.S. Coronavirus immunizations have been administered to 28.0 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases worsened, hospitalizations were not updated, and deaths worsened. The best monitoring tool, hospitalizations, has not been updated.
Believing in one’s own capabilities boosts personal resilience, shows study
The unpredictable nature of life during the coronavirus pandemic is particularly challenging for many people. Not everyone can cope equally well with the uncertainty and loss of control.
Research has shown that while a large segment of the population turns out to be resilient in times of stress and potentially traumatic events, others are less robust and develop stress-related illnesses. Events that some people experience as draining seem to be a source of motivation and creativity for others.
These differing degrees of resilience demonstrate that people recover from stressful events at different rates, with psychosocial factors such as positivity, optimism, the ability to self-regulate, social skills, problem-solving skills and social support playing a role.